𝔖 Bobbio Scriptorium

✦ LIBER ✦

702 poster COMBINED HDR BT AND 3D-CRT IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS: A DOSE ESCALATION METHOD

✍ Scribed by O. Santa Cruz; C. Marques de Jesus; V. Mendonça; J. Melich-Cerveira; G. Marcelino; I. Monteiro-Grillo

Book ID: 119519437
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 99
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(11)70824-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose Escalation With High-dose 3D-Confor

Dose Escalation With High-dose 3D-Conformal (HD-3D-CRT) or Low-dose 3D-Conformal Radiation Therapy (LD-3D-CRT+HDR-B) for Intermediate- or High-Risk Prostate Cancer: Higher Disease Control and Survival With Lower Toxicity

✍ Guix, B.; Bartrina, J.; Tello, J.; Henriquez, I.; Quinzaños, L.; Lacorte, T.; Gu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

72 poster Dose escalation by 3D conforma

72 poster Dose escalation by 3D conformal HDR brachytherapy boost in patients with intermediate or high risk localized prostate cancer: early toxicity and biochemical outcome in 80 patients

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 264 KB

297 poster Dose escalation by HDR brachy

297 poster Dose escalation by HDR brachytherapy in intermediate or high risk localized prostate cancer: early toxicity and biochemical outcome of a pilot study

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

958 poster Chronic toxicity rates in two

958 poster Chronic toxicity rates in two dose-escalation trials for intermediate/advanced prostate cancer. External-beam radiation therapy (EBRT) with high-dose rate brachytherapy (HDR-BT) boost vs adaptive radiation therapy (ART) delivered with 3D conformal or intensity-modulated techniques

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 233 KB

105 oral Analysis of acute and late morb

105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 239 KB

1095 Analysis of acute and late morbidit

1095 Analysis of acute and late morbidity and biochemical control for intermediate to high risk prostrate cancer treated with androgen deprivation, HDR and 3D/IMRT: update of a phase I–II dose escalation trial

✍ Raben, A.; Grebler, A.; Geltzeiler, J.; Hanlon, A.; Keselman, I.; Litvin, S.; Si 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 158 KB